A Study of Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery Alone

NCT03211052 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped IMP no longer available

Conditions

Prostate Cancer

Interventions

DRUG: TAK-700 and LHRH agonist
PROCEDURE: prostatectomy

Sponsor

Centre of Experimental Medicine

Collaborators

[object Object]